tapinarof
Vtama
Pharmaceutical company: Dermavant Sciences, Inc.
Pharmacologic classification:Antipsoriatic
Therapeutic classification:Aryl hydrocarbon receptor agonist
AVAILABLE FORMS
Cream: 1%
INDICATIONS AND DOSAGES
Plaque psoriasis
Adults: Apply a thin layer to psoriatic skin lesions once daily.
CONTRAINDICATIONS AND CAUTIONS
- Safety and efficacy in children haven’t been established.
- Dialyzable drug: Unlikely.
PREGNANCY-LACTATION-REPRODUCTION
- There are no adequate studies during pregnancy. Use during pregnancy only if the potential benefit justifies the fetal risk.
- It isn’t known if this drug appears in human milk. Use during breastfeeding only if the potential benefit justifies the infant risk.
INTERACTIONS
None reported.
ADVERSE REACTIONS
CNS: headache.
EENT: nasopharyngitis.
Skin: folliculitis, contact dermatitis, pruritis.
Other: flulike syndrome.
Reactions in bold italics are life-threatening.
Released: September 2022
Nursing Drug Handbook
© 2022 Wolters Kluwer